Cargando…
Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party
Multiple sclerosis (MS) is a central nervous system (CNS) disorder, which is mediated by an abnormal immune response coordinated by T and B cells resulting in areas of inflammation, demyelination, and axonal loss. Disease-modifying treatments (DMTs) are available to dampen the inflammatory aggressio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846289/ https://www.ncbi.nlm.nih.gov/pubmed/35178046 http://dx.doi.org/10.3389/fimmu.2021.813957 |
_version_ | 1784651830840524800 |
---|---|
author | Cencioni, Maria Teresa Genchi, Angela Brittain, Gavin de Silva, Thushan I. Sharrack, Basil Snowden, John Andrew Alexander, Tobias Greco, Raffaella Muraro, Paolo A. |
author_facet | Cencioni, Maria Teresa Genchi, Angela Brittain, Gavin de Silva, Thushan I. Sharrack, Basil Snowden, John Andrew Alexander, Tobias Greco, Raffaella Muraro, Paolo A. |
author_sort | Cencioni, Maria Teresa |
collection | PubMed |
description | Multiple sclerosis (MS) is a central nervous system (CNS) disorder, which is mediated by an abnormal immune response coordinated by T and B cells resulting in areas of inflammation, demyelination, and axonal loss. Disease-modifying treatments (DMTs) are available to dampen the inflammatory aggression but are ineffective in many patients. Autologous hematopoietic stem cell transplantation (HSCT) has been used as treatment in patients with a highly active disease, achieving a long-term clinical remission in most. The rationale of the intervention is to eradicate inflammatory autoreactive cells with lympho-ablative regimens and restore immune tolerance. Immunological studies have demonstrated that autologous HSCT induces a renewal of TCR repertoires, resurgence of immune regulatory cells, and depletion of proinflammatory T cell subsets, suggesting a “resetting” of immunological memory. Although our understanding of the clinical and immunological effects of autologous HSCT has progressed, further work is required to characterize the mechanisms that underlie treatment efficacy. Considering that memory B cells are disease-promoting and stem-like T cells are multipotent progenitors involved in self-regeneration of central and effector memory cells, investigating the reconstitution of B cell compartment and stem and effector subsets of immunological memory following autologous HSCT could elucidate those mechanisms. Since all subjects need to be optimally protected from vaccine-preventable diseases (including COVID-19), there is a need to ensure that vaccination in subjects undergoing HSCT is effective and safe. Additionally, the study of vaccination in HSCT-treated subjects as a means of evaluating immune responses could further distinguish broad immunosuppression from immune resetting. |
format | Online Article Text |
id | pubmed-8846289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88462892022-02-16 Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party Cencioni, Maria Teresa Genchi, Angela Brittain, Gavin de Silva, Thushan I. Sharrack, Basil Snowden, John Andrew Alexander, Tobias Greco, Raffaella Muraro, Paolo A. Front Immunol Immunology Multiple sclerosis (MS) is a central nervous system (CNS) disorder, which is mediated by an abnormal immune response coordinated by T and B cells resulting in areas of inflammation, demyelination, and axonal loss. Disease-modifying treatments (DMTs) are available to dampen the inflammatory aggression but are ineffective in many patients. Autologous hematopoietic stem cell transplantation (HSCT) has been used as treatment in patients with a highly active disease, achieving a long-term clinical remission in most. The rationale of the intervention is to eradicate inflammatory autoreactive cells with lympho-ablative regimens and restore immune tolerance. Immunological studies have demonstrated that autologous HSCT induces a renewal of TCR repertoires, resurgence of immune regulatory cells, and depletion of proinflammatory T cell subsets, suggesting a “resetting” of immunological memory. Although our understanding of the clinical and immunological effects of autologous HSCT has progressed, further work is required to characterize the mechanisms that underlie treatment efficacy. Considering that memory B cells are disease-promoting and stem-like T cells are multipotent progenitors involved in self-regeneration of central and effector memory cells, investigating the reconstitution of B cell compartment and stem and effector subsets of immunological memory following autologous HSCT could elucidate those mechanisms. Since all subjects need to be optimally protected from vaccine-preventable diseases (including COVID-19), there is a need to ensure that vaccination in subjects undergoing HSCT is effective and safe. Additionally, the study of vaccination in HSCT-treated subjects as a means of evaluating immune responses could further distinguish broad immunosuppression from immune resetting. Frontiers Media S.A. 2022-02-01 /pmc/articles/PMC8846289/ /pubmed/35178046 http://dx.doi.org/10.3389/fimmu.2021.813957 Text en Copyright © 2022 Cencioni, Genchi, Brittain, de Silva, Sharrack, Snowden, Alexander, Greco and Muraro https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Cencioni, Maria Teresa Genchi, Angela Brittain, Gavin de Silva, Thushan I. Sharrack, Basil Snowden, John Andrew Alexander, Tobias Greco, Raffaella Muraro, Paolo A. Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party |
title | Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party |
title_full | Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party |
title_fullStr | Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party |
title_full_unstemmed | Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party |
title_short | Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party |
title_sort | immune reconstitution following autologous hematopoietic stem cell transplantation for multiple sclerosis: a review on behalf of the ebmt autoimmune diseases working party |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846289/ https://www.ncbi.nlm.nih.gov/pubmed/35178046 http://dx.doi.org/10.3389/fimmu.2021.813957 |
work_keys_str_mv | AT cencionimariateresa immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty AT genchiangela immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty AT brittaingavin immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty AT desilvathushani immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty AT sharrackbasil immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty AT snowdenjohnandrew immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty AT alexandertobias immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty AT grecoraffaella immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty AT muraropaoloa immunereconstitutionfollowingautologoushematopoieticstemcelltransplantationformultiplesclerosisareviewonbehalfoftheebmtautoimmunediseasesworkingparty |